Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

生物医药行业近年来在癌症疫苗领域也获得多项进展。Moderna和默沙东联合开发的mRNA个体化癌症疫苗mRNA-4157正在多个后期临床试验中接受评估，治疗的癌症类型包括高危黑色素瘤、非小细胞肺癌、肾细胞癌、尿路上皮癌、皮肤鳞状细胞癌。它近日被行业媒 ...

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

Indications of stable vaccination rates for COVID-19 vaccines may suggest a stagnation in a key revenue stream, indicating challenges in future growth potential. mRNA is used in BioNTech’s ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

The Senate has voted to confirm the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Publicly traded ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Investing.com -- Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% ...